Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 5, Issue 5, 2008, Pages 282-290

  Bathoorn, Erik ^a   Liesker, Jeroen J W ^a   Postma, Dirkje S ^a   Boorsma, Martin ^a,b   Bondesson, Eva ^c   Köter, Gerard H ^a   Kauffman, Henk F ^a   Van Oosterhout, Antoon J M ^a   Kerstjens, Huib A M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ASTRAZENECA   (United Kingdom)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

Budesonide; Chronic obstructive pulmonary disease; Exacerbation; Formoterol Inflammation; Sputum induction

Indexed keywords

BUDESONIDE PLUS FORMOTEROL; DOXYCYCLINE; HYDROCORTISONE; IPRATROPIUM BROMIDE; PLACEBO; PREDNISOLONE; TERBUTALINE; SALBUTAMOL;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; EOSINOPHIL; FEMALE; FORCED EXPIRATORY FLOW; HUMAN; MALE; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE DETERMINATION; RADIOIMMUNOASSAY; SHORT SURVEY; SMOKING; SPUTUM;

EID: 55249091890     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412550802363360     Document Type: Article

References (36)

1. Niewoehner DE, Erbland ML, Deupree RH et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med 1999; 340(25):1941-1947.
2. Davies L, Angus RM, Calverley PM. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet 1999; 354(9177):456-460.
3. Maltais F, Ostinelli J, Bourbeau J et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med 2002; 165(5):698-703.
4. O'Byrne PM, Bisgaard H, Godard PP et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005;171(2):129-136.
5. Szafranski W, Cukier A, Ramirez A et al. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J 2003; 21(1):74-81.
6. Calverley P, Pauwels R, Vestbo J et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003; 361(9356):449-456.
7. Barczyk A, Sozanska E, Trzaska M et al. Decreased levels of myeloperoxidase in induced sputum of patients with COPD after treatment with oral glucocorticoids. Chest 2004; 126(2):389-393.
8. Culpitt SV, Rogers DF, Shah P et al. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167(1):24-31.
9. Confalonieri M, Mainardi E, Della Porta R et al. Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease. Thorax 1998; 53(7):583-585.
10. Hattotuwa KL, Gizycki MJ, Ansari TW et al. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study. Am J Respir Crit Care Med 2002; 165(12):1592-1596.
11. Balbi B, Majori M, Bertacco S et al. Inhaled corticosteroids in stable COPD patients: do they have effects on cells and molecular mediators of airway inflammation? Chest 2000; 117(6):1633-1637.
12. Llewellyn-Jones CG, Harris TA, Stockley RA. Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema. Am J Respir Crit Care Med 1996; 153(2):616-621.
13. Wilson SJ, Wallin A, Della-Cioppa G et al. Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma. Am J Respir Crit Care Med 2001; 164(6):1047-1052.
14. Wallin A, Sandstrom T, Soderberg M et al. The effects of regular inhaled formoterol, budesonide, and placebo on mucosal inflammation and clinical indices in mild asthma. Am J Respir Crit Care Med 1999; 159(1):79-86.
15. Fujimoto K, Yasuo M, Urushibata K et al. Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease. Eur Respir J 2005; 25(4):640-646.
16. Mercer PF, Shute JK, Bhowmik A et al. MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation. Respir Res 2005; 6:151.
17. Pizzichini E, Pizzichini MM, Gibson P et al. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med 1998; 158(5 Pt 1):1511-1517.
18. Brightling CE, Monteiro W, Ward R et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2000; 356(9240):1480-1485.
19. Brightling CE, McKenna S, Hargadon B et al. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax 2005; 60(3):193-198.
20. Bathoorn D, Liesker JJW, Postma DS, Bondesson E, Koëter GH, van Oosterhout AJM, Kerstjens HAM. Anti-inflammatory effect of combined budesonide/formoterol treatment in COPD exacerbations. Proceedings of the American Thoracic Society 2006; 3:A605.
21. Bathoorn D, Liesker JJW, Postma DS, Koëter GH, Kerstjens HAM. Change in inflammation during COPD exacerbations. Eur Respir J 2005; 26 Suppl. 49: 15s.
22. Quanjer PH, Tammeling GJ, Cotes JE et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16:5-40.
23. Davies L, Angus RM, Calverley PM. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet 1999; 354(9177):456-460.
24. Leidy NK, Schmier JK, Jones MK et al. Evaluating symptoms in chronic obstructive pulmonary disease: validation of the Breathlessness, Cough and Sputum Scale. Respir Med 2003; 97 Suppl A:S59-S70.
25. van der Molen T, Willemse BW, Schokker S et al. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003; 1(1):13.
26. Rutgers SR, Timens W, Kaufmann HF et al. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J 2000; 15(1):109-115.
27. Pizzichini MM, Pizzichini E, Clelland L et al. Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment. Am J Respir Crit Care Med 1997; 155(5):1501-1508.
28. Kocks JW, Tuinenga MG, Uil SM et al. Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res 2006; 7:62.
29. Saetta M, Di Stefano A, Maestrelli P et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 1994; 150(6 Pt 1):1646-1652.
30. Gan WQ, Man SF, Sin DD. Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysis. BMC Pulm Med 2005; 5(1):3.
31. Barnes NC, Qiu YS, Pavord ID et al. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease. Am J Respir Crit Care Med 2006; 173(7):736-743.
32. Takatsu K. Interleukin 5 (IL-5) and its receptor. Microbiol Immunol 1991; 35(8):593-606.
33. Emerman CL, Connors AF, Lukens TW et al. A randomized controlled trial of methylprednisolone in the emergency treatment of acute exacerbations of COPD. Chest 1989; 95(3):563-567.
34. Thompson WH, Nielson CP, Carvalho P, Charan NB, J CJ. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med 1996; 154:407-412.
35. Wood-Baker RR, Gibson PG, Hannay M et al. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005;(1):CD001288.
36. Morice AH, Morris D, Lawson-Matthew P. A comparison of nebulized budesonide with oral prednisolone in the treatment of exacerbations of obstructive pulmonary disease. Clin Pharmacol Ther 1996; 60(6):675-678.